Learn about the potential side effects of iron protein succinylate. Includes common and rare side effects information for consumers and healthcare professionals. Name: Iron protein succinylate; Accession Number: DB; Type: Small Molecule; Groups: Approved, Investigational; Description: Not. View pharmacology details for the Iron protein succinylate generic medicine.
|Published (Last):||6 March 2008|
|PDF File Size:||17.36 Mb|
|ePub File Size:||16.9 Mb|
|Price:||Free* [*Free Regsitration Required]|
Iron protein succinylate – DrugBank
Obstetrics and Gynecology By dividing the patient population according to pathological conditions iron deficiency or overt anemiaor according to the etiopathogenesis of the iron deficiency increased requirement, or increased loss in adults and in the elderlyseparate analyses on the treatment outcome were made and have been included.
Although in the first month the reference treatment appears to provide somewhat faster results, at the end of the observation, the values of hematocrit, hemoglobin and ferritin were greater in the ITF group, indicating a more progressive and steady therapeutic effect. Validation of a spectrophotometric method for the determination of iron III rion in dosage forms.
A trivalent iron protein complex has been developed using an N-acetyl-aspartylated derivative of casein Fe-ASP for oral iron therapy.
Its ifon and tolerability ifon been proved in about patients, enrolled in 3 multicenter clinical trials. Mylicon drops in the treatment of infant colic.
The open-label trial consisted of a one-week study period. Epub Dec The ITF absorption process, like that of ferritin, proceeds along the physiological pathways without bypassing the transfer system of the intestinal mucosal cells since no further increase of serum metal is observed when giving high doses of ITF to the rat pretreated with a saturating dose of ferrous sulphate. Toggle navigation Medicine India. The overall clinical rating was significantly in favor of ITFwith Clin Ther ;10 4: The criteria for the diagnosis of anemia were Hb Read More.
The general tolerability, although favorable with both treatments, was significantly more favorable with ITF Five hundred and forty-nine patients received ITF ; patients were treated with ferrous sulphate. The increase induced by iron protein succinylate was more prolonged than that of ferritin.
Iron Protein Succinylate
Iron protein succinylate is a generic medicine name and there are several brands available for it. The efficacy and tolerability of iron protein succinylate in the treatment of iron-deficiency anemia in pregnancy.
Treatment of iron deficiency conditions in blood donors: Overview of clinical trials in the treatment of iron deficiency with iron-acetyl-aspartylated casein.
Physical Medicine and Rehabilitation The absorption of iron after oral administration of 80 mg iron–protein–succinylate complex was evaluated prorein determining serum iron concentrations in 10 patients who had undergone total gastrectomy more than 1 year before and were suffering from hypochromic anaemia. The treatment outcome was checked by evaluating special hematology, symptomatology, safety hematology and hematochemistry.
A systematic review was conducted to succnylate the tolerability of several oral iron supplements based on data obtained in available publications and to report the incidence of adverse effects AEs for each supplement both overall and gastrointestinal.
ITF was prescribed to children, and a commercially available ferrous polystyrene sulphonate preparation toin a randomized double-blind, double-dummy, ten-center trial.
Recovery from energy metabolism derangement of the hepatic tissue by iron therapy. After two months of treatment, the normalization of the main hematologic parameters in both groups was detected. Acute allergic reaction to an iron compound in a milk-allergic patient. Hum Exp Toxicol Mar;22 3: Auccinylate can get this information while placing the order for iron protein succinylate with the pharmacy.
A second group of iron deficient patients with no anti H2 concurrent treatment were admitted to the same iron treatment, lasting 60 days. S Scremin L Caprioglio. Multicentre, double blind, randomised clinical trial.
G Landucci S Frontespezi.
B Manfredi F Finelli. Flavio Lazzari Maria Carrara. A total of children up to the age of 14 years were treated for iron deficiency or overt anemia. The iroj of simethicone available in liquid form as Mylicon Drops in the treatment of infant colic was assessed in 51 healthy infants between 2 and 12 weeks of age.
Iron protein succinylate Side Effects in Detail –
J Pharm Biomed Anal Aug;29 6: This accounts for a better tolerability of the compound compared with iron salts, during the treatment of iron deficiency. Tolerability of suxcinylate oral iron supplements: Meta-analysis of efficacy and tolerability data on iron proteinsuccinylate in patients with iron deficiency anemia of different severity. Five hundred and forty-nine patients received ITF ; patients succinylatr treated with ferrous sulphate.
Serum iron concentration significantly increased compared with baseline values only in patients given iron protein succinylate. The main property of the derivative is to keep iron bonded at acidic pH values. Histological damage to the gastroduodenal mucosa was evaluated using light and electron microscopy.
Evaluation of the siderohaemic curve after loading administration of iron–protein–succinylate to gastrectomized subjects: Nine orotein gynaecologic ptotein located in Mexico.
Dietary iron deficiency in the rat. Studying the gastrointestinal motor effects of iron compounds may help to elucidate the mechanism originating the gastrointestinal side effects of frequently reported during martial therapy.
Involvement of iron ferric reduction in the iron absorption mechanism of a trivalent iron-protein complex iron protein succinylate.
Chemical and biological characterization of iron-protein succinylate ITF Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children. Pharmacological and biopharmacological characteristics of legofer ferric protein succinylate ].